Shell Asset Management CO Ani Pharmaceuticals Inc Transaction History

Shell Asset Management CO

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$31.9 - $41.95 $19,012 - $25,002	-596 Reduced 18.4%	2,644 $106,000
Q3 2022 Nov 14, 2022	SELL	$29.83 - $38.01 $25,087 - $31,966	-841 Reduced 20.61%	3,240 $104,000
Q2 2022 Aug 09, 2022	BUY	$23.09 - $33.46 $277 - $401	12 Added 0.29%	4,081 $121,000
Q1 2022 May 04, 2022	SELL	$26.91 - $47.15 $16,119 - $28,242	-599 Reduced 12.83%	4,069 $114,000
Q4 2021 Feb 09, 2022	BUY	$32.97 - $56.85 $527 - $909	16 Added 0.34%	4,668 $215,000
Q3 2021 Nov 04, 2021	SELL	$26.48 - $35.99 $4,501 - $6,118	-170 Reduced 3.53%	4,652 $153,000
Q2 2021 Aug 12, 2021	BUY	$31.86 - $38.6 $8,283 - $10,036	260 Added 5.7%	4,822 $169,000
Q1 2021 May 10, 2021	BUY	$28.4 - $36.14 $129,560 - $164,870	4,562 New	4,562 $165,000

211

18.8M

11.7K

10.5K

Ticker ANIP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 17,426,000
Market Cap $986M
Description
ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...

Get notified when there are updates to the investment portfolio of Shell Asset Management CO, based on Form 13F filings with the SEC.

Stay updated on Shell Asset Management CO with notifications on news.